- Report
- March 2024
- 197 Pages
Global
From €3253EUR$3,374USD£2,782GBP
€3614EUR$3,749USD£3,091GBP
- Report
- October 2023
- 182 Pages
Global
From €4724EUR$4,900USD£4,040GBP
- Report
- January 2024
- 156 Pages
Global
From €3647EUR$3,783USD£3,119GBP
€4290EUR$4,450USD£3,669GBP
- Report
- January 2024
- 156 Pages
Global
From €3647EUR$3,783USD£3,119GBP
€4290EUR$4,450USD£3,669GBP
- Report
- May 2024
- 301 Pages
Global
From €5254EUR$5,450USD£4,494GBP
- Report
- August 2021
- 137 Pages
Global
From €5736EUR$5,950USD£4,906GBP
- Report
- May 2020
- 92 Pages
North America
From €2025EUR$2,100USD£1,732GBP
€2892EUR$3,000USD£2,474GBP
- Report
- May 2020
- 114 Pages
Asia Pacific
From €2025EUR$2,100USD£1,732GBP
€2892EUR$3,000USD£2,474GBP
- Report
- May 2020
- 110 Pages
Europe
From €2025EUR$2,100USD£1,732GBP
€2892EUR$3,000USD£2,474GBP
- Report
- April 2020
- 147 Pages
Global
From €3071EUR$3,185USD£2,626GBP
€4387EUR$4,550USD£3,752GBP
- Report
- November 2022
- 150 Pages
Global
From €5303EUR$5,500USD£4,535GBP
- Report
- December 2019
- 69 Pages
Europe
From €1446EUR$1,500USD£1,237GBP
- Report
- December 2019
- 170 Pages
Global
From €3471EUR$3,600USD£2,968GBP
- Report
- December 2019
- 69 Pages
Middle East, Africa, Latin America Middle East, Africa, Latin America
From €1446EUR$1,500USD£1,237GBP
- Report
- December 2019
- 69 Pages
Asia Pacific
From €1446EUR$1,500USD£1,237GBP
- Report
- December 2019
- 58 Pages
North America
From €1446EUR$1,500USD£1,237GBP
- Report
- August 2018
- 106 Pages
Global
From €2410EUR$2,500USD£2,061GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- July 2023
- 94 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- May 2024
- 50 Pages
Global
From €2555EUR$2,650USD£2,185GBP
Carnitine is a biotechnology product derived from the amino acid lysine. It is used in a variety of applications, including dietary supplements, sports nutrition, and medical treatments. Carnitine is essential for the transport of fatty acids into the mitochondria, where they are used to produce energy. It is also used to treat certain medical conditions, such as heart disease, kidney disease, and diabetes.
The global carnitine market is driven by the increasing demand for dietary supplements and sports nutrition products. The growing awareness of the health benefits of carnitine is also driving the market. Additionally, the increasing prevalence of chronic diseases, such as heart disease and diabetes, is expected to drive the market.
Some of the major companies in the carnitine market include Lonza Group, Glanbia plc, Ajinomoto Co., Inc., and BASF SE. Show Less Read more